ALYSIA KRETSCHMAR: Open Payments
NPI 1326682956 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 47 payments from 13 companies in 2025. Trend: 2023 $299 · 2024 $371 · 2025 $791
Food & beverage: $791
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $136 |
| Exact Sciences Corporation | 6 | $133 |
| Lilly USA, LLC | 7 | $122 |
| ABBVIE INC. | 3 | $43 |
| PFIZER INC. | 2 | $36 |
| Amgen Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Ascendis Pharma Endocrinology Inc | 2 | $28 |
| Dexcom, Inc. | 1 | $22 |
Products named: CAPLYTA, Cologuard Collection Kit, Ozempic, MOUNJARO, Wegovy, PREVNAR 20, Rybelsus, OTEZLA.
Industry payments across MI — which companies pay providers there.
